A classification of nuclear aberration in relation to malignancy associated changes (MAC).
D000328:Adult; D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000473:pathology; D002452:Cell Count; D002454:Cell Differentiation; D002467:Cell Nucleus; D002471:Cell Transformation, Neoplastic; D002843:Chromatin; D002940:Circadian Rhythm; D003110:Colonic Neoplasms / Q000473:pathology; D003581:Cytodiagnosis; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology; D008297:Male; D008545:Melanoma / Q000473:pathology; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009061:Mouth Mucosa / Q000166:cytology*; D009362:Neoplasm Metastasis; D010190:Pancreatic Neoplasms / Q000473:pathology; D011565:Psoriasis / Q000188:drug therapy; D013964:Thyroid Neoplasms / Q000473:pathology; D013997:Time Factors
D002843:Chromatin; D008727:Methotrexate